Brief: Pharmiva Names Anna Linton New CEO
April 4 (Reuters) - Pharmiva AB (publ) PHARM.ST :
* NAMES ANNA LINTON NEW CEO
* LINTON TO REPLACE CHRISTINA ÖSTBERG LLOYD, WHO WILL LEAVE
POSITION ON APRIL 30
* DEPUTY CEO KAROLINE AKERJORDET TO BE INTERIN CEO FROM MAY
1
UNTIL THE NEW CEO JOINS
* LINTON TO START AS CEO ON AUG 8
Source text for Eikon: ID:nMFN8G1sBb
Further company coverage: PHARM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharmiva AB (publ)
See all newsBrief: Merger Between Peptonic, Pharmiva Creates Leading Global Femtech Company
Brief: Pharmiva Q2 Oper Loss Narrows To SEK 6 Mln
Brief: Pharmiva, Peptonic Announce Merger Plan
Brief: Pharmiva AB Prelim Jan-May Operating Loss Narrows To SEK 8.9 Mln
Brief: Pharmiva Q1 Loss Before And After Tax Narrows To SEK 5.3 Mln